A. Meguid El Nahas
Research Subjects
A. Meguid El Nahas has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Ahmed F. El‐Koraie
University of Alexandria, Alexandria, Egypt
1 shared publicationAhmed G. Adam
University of Alexandria Alexandria Egypt and
1 shared publication- Alaa Sabry
Mansoura Urology and Nephrology Center, Mansoura University, Mansoura, Egypt
1 shared publication - Anna M. Grabowskab
Ex Vivo Cancer Pharmacology Centre, Translational Medical Sciences, Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UK
1 shared publication Bart E. Wagner
1 shared publicationEssam H. El‐Kashef
University of Alexandria Alexandria Egypt and
1 shared publication
Latest Publications
- 17 January 2006
- Published by Wiley in Seminars in Dialysis
- Vol. 19 (1) , 60-68
Vascular Calcifications in Uremia: Old Concepts and New Insights
The annual mortality rate in uremic patientscorrected for agesexand raceis significantly higher than in the general population. This is primarily due to cardiovascular events. Vascular calcifications play a vital role in the development of cardiovascular morbidity and subsequent increased mortality. Vascular calcification affects both vascular intima and media layers and its mechanism remains poorly understood. Over the last few years it has been shown thatin addition to traditional cardiovascular risk factorsdisturbances in mineral metabolism in the uremic milieucalcium‐containing phosphate bindersand vitamin D treatment of secondary hyperparathyroidism may contribute to the pathogenesis of vascular calcifications. Other uremia‐related risk factors (e.g.increased oxidized low‐density lipoprotein cholesteroluremic toxinsincreased oxidative stressdialysis and dialysate‐related factorshemodynamic overloadhyperhomocysteinemia) may also play a role. In uremic patientsapart from these facilitating factorsdecreased levels of endogenous calcification inhibitors such as fetuin‐Amatrix Gla proteinosteoprotegerinand osteopontin have also been associated with increased calcium‐phosphate precipitation in extraskeletal tissues. Finallyvascular calcification is the outcome of the active and dynamic balance of procalcifying and anticalcifying influences. For the prevention and treatment of vascular calcificationsit is essential to avoid treatment modalities that lead to calcium overloadachieve good metabolic controland optimize dialysis.
- 17 January 2006
- Published by Wiley in Seminars in Dialysis
- Vol. 19 (1) , 60-68
Vascular Calcifications in Uremia: Old Concepts and New Insights
The annual mortality rate in uremic patientscorrected for agesexand raceis significantly higher than in the general population. This is primarily due to cardiovascular events. Vascular calcifications play a vital role in the development of cardiovascular morbidity and subsequent increased mortality. Vascular calcification affects both vascular intima and media layers and its mechanism remains poorly understood. Over the last few years it has been shown thatin addition to traditional cardiovascular risk factorsdisturbances in mineral metabolism in the uremic milieucalcium‐containing phosphate bindersand vitamin D treatment of secondary hyperparathyroidism may contribute to the pathogenesis of vascular calcifications. Other uremia‐related risk factors (e.g.increased oxidized low‐density lipoprotein cholesteroluremic toxinsincreased oxidative stressdialysis and dialysate‐related factorshemodynamic overloadhyperhomocysteinemia) may also play a role. In uremic patientsapart from these facilitating factorsdecreased levels of endogenous calcification inhibitors such as fetuin‐Amatrix Gla proteinosteoprotegerinand osteopontin have also been associated with increased calcium‐phosphate precipitation in extraskeletal tissues. Finallyvascular calcification is the outcome of the active and dynamic balance of procalcifying and anticalcifying influences. For the prevention and treatment of vascular calcificationsit is essential to avoid treatment modalities that lead to calcium overloadachieve good metabolic controland optimize dialysis.
- Open Access
- 1 May 2002
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 17 (5) , 803-812
Cytoskeletal protein expression and regenerative markers in schistosomal nephropathy
Background. Progression of renal diseases is related to the abnormal regulation of cellular and extracellular matrix turnover. Other factors in addition to schistosomal antigens may be relevant to the progression of schistosomal nephropathy (SN). The validity of markers of fibroblastic differentiation, alpha smooth muscle actin (αSMA), and vimentin, as well as the regenerative activity (PCNA/apoptosis index) in determination of progression of SN in comparison to other forms of non‐schistosomal nephropathy (non‐SN) is investigated. Methods. Three groups were included; group I pure SN (n=16), group II a diverse group of non‐schistosomal patients with comparable pathologic changes on renal biopsy (n=40) and a control group (n=5). Immunohistochemical staining of myofibroblasts (αSMA and vimentin) and proliferating cells (PCNA) and histomorphometric analysis was done. In situ end labelling (ISEL) of DNA was used to evaluate apoptosis. Results. No differences in the patterns of distribution of positivity of the different studied markers were observed between the different nephropathy groups. Both αSMA and vimentin were detected in glomerular mesangial, tubular epithelial, interstitial inflammatory fibroblast‐like cells and occasionally endothelial cells. PCNA and apoptotic cells were detected in tubular epithelial and interstitial cells with paucity of positive cells in the glomerulus. Significant positive correlations were detected in group I between glomerular sclerosis and interstitial markers including interstitial αSMA (r=0.609, P=0.001), interstitial vimentin (r=0.812, P=0.00) and interstitial apoptosis (r=0.733, P=0.001). On the other hand, glomerulosclerosis in group II showed significant positive correlations with predominantly the glomerular markers; glomerular αSMA (r=0.475, P=0.002), glomerular apoptosis (r=0.684, P=0.00) and glomerular PCNA (r=0.691, P=0.00). Interstitial fibrosis correlated significantly with interstitial markers in group I including interstitial αSMA (r=0.837, P=0.00) interstitial vimentin (r=0.929, P=0.00), interstitial apoptosis (r=0.807, P=0.00) and interstitial PCNA (r=0.617, P=0.01), while in group II it correlated with both interstitial and glomerular markers. In addition, the tubulo‐interstitial ratio was significantly higher in group I in comparison with group II (P=0.024), with no difference between groups II and III. Conclusions. Although SN may start as glomerulopathy associated with increased mesangial cellularity, the interstitial rather than the glomerular markers of myofibroblastic differentiation and those of cell turnover are playing a crucial role in late stages of schistosomal, but not in non‐schistosomal nephropathies.
- 1 May 2002
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 17 (5) , 803-812
Open AccessCytoskeletal protein expression and regenerative markers in schistosomal nephropathy
Background. Progression of renal diseases is related to the abnormal regulation of cellular and extracellular matrix turnover. Other factors in addition to schistosomal antigens may be relevant to the progression of schistosomal nephropathy (SN). The validity of markers of fibroblastic differentiation, alpha smooth muscle actin (αSMA), and vimentin, as well as the regenerative activity (PCNA/apoptosis index) in determination of progression of SN in comparison to other forms of non‐schistosomal nephropathy (non‐SN) is investigated. Methods. Three groups were included; group I pure SN (n=16), group II a diverse group of non‐schistosomal patients with comparable pathologic changes on renal biopsy (n=40) and a control group (n=5). Immunohistochemical staining of myofibroblasts (αSMA and vimentin) and proliferating cells (PCNA) and histomorphometric analysis was done. In situ end labelling (ISEL) of DNA was used to evaluate apoptosis. Results. No differences in the patterns of distribution of positivity of the different studied markers were observed between the different nephropathy groups. Both αSMA and vimentin were detected in glomerular mesangial, tubular epithelial, interstitial inflammatory fibroblast‐like cells and occasionally endothelial cells. PCNA and apoptotic cells were detected in tubular epithelial and interstitial cells with paucity of positive cells in the glomerulus. Significant positive correlations were detected in group I between glomerular sclerosis and interstitial markers including interstitial αSMA (r=0.609, P=0.001), interstitial vimentin (r=0.812, P=0.00) and interstitial apoptosis (r=0.733, P=0.001). On the other hand, glomerulosclerosis in group II showed significant positive correlations with predominantly the glomerular markers; glomerular αSMA (r=0.475, P=0.002), glomerular apoptosis (r=0.684, P=0.00) and glomerular PCNA (r=0.691, P=0.00). Interstitial fibrosis correlated significantly with interstitial markers in group I including interstitial αSMA (r=0.837, P=0.00) interstitial vimentin (r=0.929, P=0.00), interstitial apoptosis (r=0.807, P=0.00) and interstitial PCNA (r=0.617, P=0.01), while in group II it correlated with both interstitial and glomerular markers. In addition, the tubulo‐interstitial ratio was significantly higher in group I in comparison with group II (P=0.024), with no difference between groups II and III. Conclusions. Although SN may start as glomerulopathy associated with increased mesangial cellularity, the interstitial rather than the glomerular markers of myofibroblastic differentiation and those of cell turnover are playing a crucial role in late stages of schistosomal, but not in non‐schistosomal nephropathies.
- Open Access
- 1 February 2002
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 17 (2) , 239-245
A comprehensive study of the association between hepatitis C virus and glomerulopathy
Background. Hepatitis C virus (HCV)‐related infection is commonly associated with a wide range of glomerulonephritides (GN) including membranoproliferative glomerulonephritis (MPGN). The causal link between HCV infection and renal disease has been postulated through the induction of cryoglobulinaemia and secondary GN. However, the detection of viral particles or genomes within the kidneys of HCV‐infected patients has proved to be difficult. With that in mind, we have studied a population of Egyptian HCV‐positive patients with associated GN in an attempt to detect viral particles, antigens or RNA within their kidneys. Methods. Fifty patients were found to be HCV positive out of 303 who presented with a glomerulopathy between 1998 and 1999 at the Mansoura Urology and Nephrology Center, Egypt. Comprehensive investigations of these 50 patients were undertaken including an evaluation of their clinical, biochemical, histological, virological and immunological parameters. In addition, their kidney biopsy material was analysed by electron microscopy (EM) to detect viral particles, by immunohistochemistry to detect a viral core antigen and by RT–PCR to detect RNA. This was compared with 50 HCV‐negative controls. Results. Positivity for HCV antibodies was higher among patients with GN (38%) compared with healthy blood donors (16%). Genotype 4 was sequenced in 70% of the HCV‐positive samples examined. MPGN was the most common type of GN accounting for 54% of patients. Extrarenal manifestations were absent in the majority (80%) of patients even though 54% had cryoglobulinaemia. EM revealed virus‐like particles in 50% of biopsies. Immunohistochemistry failed to reveal HCV‐related antigens in kidney sections. HCV RNA was detected in the cryoprecipitates in 66% of patients and 22% of frozen renal sections. Control sections were negative. Conclusion. Our findings suggest a causal link between HCV and GN based on the observation of virus‐like particles as well as viral RNA within the kidney sections of patients with HCV‐associated glomerulopathies.
- 1 February 2002
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 17 (2) , 239-245
Open AccessA comprehensive study of the association between hepatitis C virus and glomerulopathy
Background. Hepatitis C virus (HCV)‐related infection is commonly associated with a wide range of glomerulonephritides (GN) including membranoproliferative glomerulonephritis (MPGN). The causal link between HCV infection and renal disease has been postulated through the induction of cryoglobulinaemia and secondary GN. However, the detection of viral particles or genomes within the kidneys of HCV‐infected patients has proved to be difficult. With that in mind, we have studied a population of Egyptian HCV‐positive patients with associated GN in an attempt to detect viral particles, antigens or RNA within their kidneys. Methods. Fifty patients were found to be HCV positive out of 303 who presented with a glomerulopathy between 1998 and 1999 at the Mansoura Urology and Nephrology Center, Egypt. Comprehensive investigations of these 50 patients were undertaken including an evaluation of their clinical, biochemical, histological, virological and immunological parameters. In addition, their kidney biopsy material was analysed by electron microscopy (EM) to detect viral particles, by immunohistochemistry to detect a viral core antigen and by RT–PCR to detect RNA. This was compared with 50 HCV‐negative controls. Results. Positivity for HCV antibodies was higher among patients with GN (38%) compared with healthy blood donors (16%). Genotype 4 was sequenced in 70% of the HCV‐positive samples examined. MPGN was the most common type of GN accounting for 54% of patients. Extrarenal manifestations were absent in the majority (80%) of patients even though 54% had cryoglobulinaemia. EM revealed virus‐like particles in 50% of biopsies. Immunohistochemistry failed to reveal HCV‐related antigens in kidney sections. HCV RNA was detected in the cryoprecipitates in 66% of patients and 22% of frozen renal sections. Control sections were negative. Conclusion. Our findings suggest a causal link between HCV and GN based on the observation of virus‐like particles as well as viral RNA within the kidney sections of patients with HCV‐associated glomerulopathies.